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HEMATOPOIESIS
Differentiation of the Mononuclear Phagocyte System During Mouse
Embryogenesis: The Role of Transcription Factor PU.1
By Agnieszka M. Lichanska, Catherine M. Browne, Gregory W. Henkel, Kathleen M. Murphy,
Michael C. Ostrowski, Scott R. McKercher, Richard A. Maki, and David A. Hume
During mouse embryogenesis, macrophage-like cells arise
first in the yolk sac and are produced subsequently in the
liver. The onset of liver hematopoiesis is associated with the
transition from primitive to definitive erythrocyte produc-
tion. This report addresses the hypothesis that a similar
transition in phenotype occurs in myelopoiesis. We have
used whole mount in situ hybridization to detect macro-
phage-specific genes expressed during mouse development.
The mouse c-fms mRNA, encoding the receptor for macro-
phage colony-stimulating factor (CSF-1), was expressed on
phagocytic cells in the yolk sac and throughout the embryo
before the onset of liver hematopoiesis. Similar cells were
detected using the mannose receptor, the complement recep-
tor (CR3), or the Microphthalmia transcription factor (MITF)
as mRNA markers. By contrast, other markers including the
F4/80 antigen, the macrophage scavenger receptor, the
S-100 proteins, S100A8 and S100A9, and the secretory
product lysozyme appeared later in development and ap-
peared restricted to only a subset of c-fms–positive cells.
Two-color immunolabeling on disaggregated cells con-
firmed that CR3 and c-fms proteins are expressed on the
same cells. Among the genes appearing later in develop-
ment was the macrophage-restricted transcription factor,
PU.1, which has been shown to be required for normal adult
myelopoiesis. Mice with null mutations in PU.1 had normal
numbers of c-fms–positive phagocytes at 11.5dpc. PU.1(2/2)
embryonic stem cells were able to give rise to macrophage-
like cells after cultivation in vitro. The results support previ-
ous evidence that yolk sac–derived fetal phagocytes are
functionally distinct from those arising in the liver and
develop via a different pathway.
r 1999 by The American Society of Hematology.
THE MONONUCLEAR phagocyte system is defined as afamily of cells that arise from hematopoietic progenitors
in bone marrow and progress through monoblasts and promono-
cytes to monocytes.1 At this stage, they enter the circulation and
migrate into the tissues to become mature macrophages. The
production of monocytes and macrophages in adult mice is
controlled by macrophage colony-stimulating factor (M-CSF or
CSF-1),2 which acts through a specific plasma membrane
receptor encoded by c-fms proto-oncogene.3,4 Granulocyte-
macrophage colony-stimulating factor, interleukin-3 (IL-3), and
many other cytokines/lymphokines can regulate monocytopoi-
esis in vitro or in vivo.5,6
Electron microscopic studies of early embryonic develop-
ment have identified the first cells with the ultrastructural
appearance of tissue macrophages in the yolk sac before they
appear in the embryo. Putative phagocytes infiltrate the head
and much of the rest of the body at the same time as the first
pluripotent hematopoietic progenitor cells can be detected in the
aorta-gonad-mesonephros (AGM) and subsequently in the
liver7,8; that is, around 10 days postcoitum (dpc). The origin of
early embryonic phagocytes in the yolk sac has been demon-
strated most convincingly via the use of chick-quail chimeras.9
Yolk sac ‘‘macrophages’’ appear to develop without passing
through an obvious monocyte stage, as evidenced by the lack of
markers such as peroxidase and the monocyte surface marker,
ER-MP20, and continue to proliferate actively once they have
infiltrated the embryo.10,11 Within the embryo, macrophage-like
cells are associated with the rapid removal of apoptotic
cells,12-15 perhaps the most striking example being in the region
between the developing digits.16 Removal of dying cells by
specialized, migratory phagocytes is a function conserved
across evolution; mechanisms and receptors identified in Dro-
sophila and Caenorhabditis elegans have clear parallels in
mice. Drosophila hemocytes that remove dying cells, like
mammalian phagocytes, express a CD36 family member and
scavenger receptors.17-19 The mouse homolog of C elegans cell
death gene ced-7 is expressed in fetal phagocytes and is
required for removal of dying cells.20 Evidence from Dro-
sophila21,22 to mouse12 indicates that cell death precedes macro-
phage infiltration, and that dying cells can influence migration
and differentiation of the macrophage-like cells. Apart from the
obvious role in clearance, fetal phagocytes are very closely
associated with the developing vasculature23 and may control
angiogenesis as they do in adults.
The first documented surface marker for the appearance of
macrophage-like cells in the mouse was the F4/80 antigen, an
unusual member of the serpentine receptor family of unknown
function.24 Immunocytochemical localization of F4/80 showed
positive cells in the yolk sac and head around 10.5 dpc and
subsequently identified phagocytes in regions of tissue turnover
and cell death.13 We subsequently applied the technique of
whole mount in situ hybridization to localize c-fms mRNA.
Cells with detectable levels of c-fms mRNA appeared simulta-
neously in the yolk sac and the embryo around 9.5 dpc. Later
they were not only associated with presumptive hematopoietic
cells in the developing liver,25 but were also observed through-
out the body of the developing embryo, with particularly high
frequency found in the sites of known tissue turnover including
interdigital spaces and the brain. More recently, the b2 integrin,
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CD11b (Mac-1), was localized in the embryo in a pattern that
appears roughly consistent with c-fms.26
The differentiation of myeloid cells is controlled by specific
transcription factors. The first exon of the murine and human
c-fms gene that is transcribed in macrophages is flanked by a
promoter that contains binding sites for the myeloid-restricted
transcription factor PU.1.27-30 We have recently shown that
these sites alone constitute a macrophage-specific minimal
promoter.31 Similar binding sites are present in promoters of
other macrophage-restricted genes, including tartrate resistant
acid phosphatase (TRAP), lysozyme M, macrophage scavenger
receptor, IL-1b, Fc receptors (FcgRI and FcgRIIIA) and CD11b
(integrin adhesion molecule).32-38 Two groups have indepen-
dently shown that a targeted disruption of the PU.1 gene causes
gross reduction in myeloid differentiation.39,40 Although the
formation of macrophage colonies from fetal liver progenitor
cells was disrupted and there was no evidence of mature cells
defined by markers such as the F4/80 antigen in tissues of
knockout animals, expression of c-fms mRNA was still detect-
able by reverse transcriptase-polymerase chain reaction (RT-
PCR) in early embryos.41 In one of these knockouts at least, null
mice are able to proceed to birth and morphogenesis is
normal.39 The knockout phenotype was difficult to interpret in
the absence of studies on PU.1 expression during development.
In this report, we present evidence that the onset of hematopoi-
esis in the liver marks a clear transition in the phenotype and
pathway of differentiation of phagocytes in the embryo, and we
show that expression of PU.1 is associated with this transition.
MATERIALS AND METHODS
Animals
Naturally mated outbred mice (CD1 or Swiss Quackenbush) were
killed by cervical dislocation on days 9.5 to 13.5 of development (day
0.5, morning of vaginal plug). The embryos were delivered by cesarean
section, then dissected out of the decidua with the yolk sac and the
amnion pulled away from the embryo, but retained attached. In embryos
of 10.5 dpc and older, the head and heart were punctured with a
27-gauge needle to prevent the trapping of reagents in the lumen. Viable
PU.1(1/2) mice were also naturally mated and killed by cervical
dislocation on days 10.0 to 12.5 dpc. The embryos were genotyped by
PCR on genomic DNA using one of the embryonic limbs as the source
of DNA. The primers used were: PuKO 58 primer: 58 GCC CCG GAT
GTG CTT CCC TTA TCA AAC C 38, Pu920 38 primer: 58 TGC CTC
GGC CCT GGG AAT GTC 38, neo.1 38 primer: 58 CGC ACG GGT
GTT GGG TCG TTT TGT TGG G 38.42
Embryonal stem (ES) cells culture and differentiation. D3 parent
ES cells and PU.1(1/2) and (2/2) lines derived from them were
described previously.42 They were cultured in flasks precoated with
0.1% (wt/vol) gelatin (Sigma, St Louis, MO) and seeded with neoR
mitotically inactivated embryonic fibroblast feeders (a gift from Dr S.
Delaney, CMCB, University of Queensland, Queensland, Australia). ES
cells were plated at low density in these flasks in Dulbecco’s modified
Eagle’s medium (DMEM) containing high glucose and Na pyruvate
15% fetal calf serum (FCS), 2 mmol/L L-glutamine, 30 µg/mL
penicillin, 100 µg/mL streptomycin, 0.1 mmol/L b-mercaptoethanol,
and 1 3 103 U leukemia inhibitory factor (LIF) (ESGRO, Amrad,
Melbourne)/mL. ES cells were passaged by digestion with 0.25%
trypsin (37°C; 3 to 5 minutes). The cells were washed in LIF-containing
medium. Cells that were to be differentiated were resuspended in
differentiation medium (DMEM supplemented with batch-selected 15%
FCS (CSL, Melbourne, Australia), 0.1 mmol/L nonessential amino
acids (GIBCO), 0.1 mmol/L b-mercaptoethanol, 5 3 103 U/mL of
recombinant human CSF-1 (Chiron Corp, Emeryville, CA), 10 U/mL of
human recombinant IL-3 (a gift from Dr A. Hapel, ANU, Canberra,
Australia), at the final concentration of 1 3 105 cells/mL of differentia-
tion medium and plated out into 10-cm bacteriological grade culture
dishes. Medium was changed every 2 to 3 days as embryoid bodies
developed and subsequently macrophage-like cells appeared attached to
the surface.43
Latex beads phagocytosis assay. Latex beads (1.16 µm in diameter)
(Sigma) were purchased as 10% (wt/vol) aqueous suspension. They
were washed and resuspended in sterile phosphate-buffered saline
(PBS) at the same concentration. The beads were added to the cells at a
final concentration of 0.01% (wt/vol), and the cells were incubated at
37°C, 5% CO2, and monitored for phagocytosis between 1 and 4 hours.
The cells were then washed twice with PBS and fixed in 1%
glutaraldehyde (Sigma) for 30 minutes at room temperature, washed
twice with PBS, and stored in fresh PBS at 4°C.
In situ hybridization. The probes were made and labeled using
digoxygenin (DIG) RNA labeling mix according to the manufacturer’s
instructions (Boehringer Mannheim, Mannheim, Germany), using T7
and T3 polymerases from Promega (Madison, WI), and Sp6 from
Boehringer Mannheim. Probes were stored at 270°C until required.
The probes used, their sizes, and the enzymes required for linearization
are listed in Table 1. Mannose receptor cDNA was obtained from A.
Ezekowitz (Harvard University, Boston, MA), scavenger receptor
cDNA from M. Krieger (Massachusetts Institute of Technology, Boston,
MA), lysozyme cDNA from R. Renkawitz (Max Planck Institute,
Martinsried, Germany), and CP10 and MRP14 (S100A8 and S100A9)
from C. Geczy (University of NSW, Sydney, Australia). Vectors cut
with PstI were end-filled using Klenow polymerase at 12°C.
The whole-mount in situ hybridization was performed as described
previously.25 Embryos were fixed in 4% paraformaldehyde (PFA)
overnight at 4°C and permeabilized with proteinase K (10 µg/mL) for
15 minutes at 9.5 dpc and 5 minutes more for each extra day of
development. Embryos were prehybridized for at least 2 hours at 65°C
and then hybridized overnight using 0.5 µg/mL of labeled probe.
Posthybridization washes were also performed at 65°C. Washed em-
bryos were blocked using 10% sheep serum, 2% bovine serum albumin
(BSA) in TBTX (Tris-HCl pH 7.5, 150 mmol/L NaCl, and 0.1% Triton
X-100) for at least 3 hours and then incubated overnight with anti-DIG
F(ab8)2 fragments conjugated to alkaline phosphatase (Boehringer
Mannheim). Labeled probes were detected using a colorimetric method
using NBT (4-nitroblue tetrazolium chloride) and BCIP (5-bromo-4-
chloro-3-indolyl-phosphate) (Boehringer Mannheim). As a negative
control, the embryos were incubated with the corresponding sense
probe. In none of the cases shown was there any specific signal obtained
with the sense probe.
Histology
The stained embryos were refixed in 4% PFA, cleared in xylene, and
embedded in paraffin wax. A total of 7- to 8-µm sections were floated in
a waterbath onto slides, dried, dewaxed, and mounted after counterstain-
Table 1. Plasmids and Probes Used for In Situ Hybridization
Probe Plasmid
Size
(bp)
Fragment
Antisense Sense
c-fms pGEM2 ,800 NdeI or HindIII EcoRI
MMR pManR431 431 AvaI HincII
MSR pJA18 1,444 HindIII XbaI
PU.1 pOK PU.1S 1,100 — XhoI
pOK PU.1A XhoI —
S100A8 pCP 14 300 EcoRI —
Lysozyme pBS 300 PstI EcoRI
S100A9 pGEM 300 XbaI PstI
F4/80 pBS F4/80 630 KpnI SpeI
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ing with neutral red or hematoxylin as required. Unstained slides were
viewed with Nomarski optics and the stained sections with bright field
on an Olympus microscope (AX70).
Immunocytochemistry
ES cell-derived macrophages were fixed in 4% PFA/PBS (Sigma) for
30 minutes at room temperature. The cells were then washed in PBS and
incubated with ice-cold methanol containing 0.5% (vol/vol) H2O2 to
quench any endogenous peroxidase activity. Nonspecific protein bind-
ing was blocked by incubating the cells with 10% FCS in PBS for 10
minutes at room temperature. The primary rat antimouse F4/80
antibody (as rat hybridoma supernatant) was diluted 1:100 in PBS
containing 10% FCS and then added to the cells for 60 minutes at room
temperature. The primary antibody was detected with a secondary
antirat horseradish peroxidase-linked antibody for 60 minutes at room
temperature. A solution of 0.5 mg diaminobenzidine (DAB) sub-
strate/mL (Sigma) supplemented with 1 µL/mL of 30% H2O2 was added
to detect the antibody for a maximum of 10 minutes. Cells were
monitored during this time for the emergence of an orange-brown stain,
which indicated the presence of the surface antigen F4/80.
Photography
Photographs of whole mounts were taken on a Leica dissecting
microscope with cold lamp side illumination using Kodak T64 film.
Photographs of sections were taken on an Olympus AX70 microscope
using Kodak daylight film under Nomarski optics (unstained) or bright
field (stained sections), and finally the photographs of cells in culture
were taken on an inverted Olympus microscope using Kodak T160 film
and Nomarski optics.
Flow Cytometry
Embryos were disaggregated using a modified method of Yoder et
al.44 Briefly, the yolk sacs (10 to 13.5 dpc), embryos (10.0 and 11.5 dpc),
or fetal livers (10.5 to 12.5 dpc) were dissected free and washed in PBS.
They were then drawn through an 18G (yolk sacs 11.5 to 13.5 dpc) or
23-gauge needle and transferred to a petri dish and incubated with 0.1%
collagenase D; 0.2% dispase (Boehringer) in PBS/20%FCS for 60
minutes at 37°C. Dispersed cells were drawn through a 23-gauge needle
into a syringe, pelleted by centrifugation, washed in PBS, and counted.
If required, the cells were cultured in medium containing 5 3 103 Cetus
U/mL of recombinant human CSF-1 (Chiron Corp) in bacteriological
petri dishes.45
The cells were stained as described previously46 except that 5% rat
serum was used for blocking rather than purified IgG. Anti–c-fms
monoclonal antibody was used as 1/100 dilution of hybridoma superna-
tant,47 commercial reagents were goat antirat FITC F(ab8)2 fragments
(Serotec, Oxford, UK), anti-F4/80 PE/Cy5 antibody (Serotec), and
anti-Mac-I PE antibody (Caltag, Burlingame, CA). Note that the three
rat antibodies are each IgG2B and effectively act as isotype controls for
each other. Analyses were performed on a FACSCalibur flow cytometer
(Becton Dickinson, San Jose, CA), and samples were analyzed using
the associated CellQuest software.
RESULTS
Location of c-fms–Positive Cells by Whole-Mount In Situ
Hybridization Shows a Large Population of Phagocytes
in the Embryo
The detection of c-fms–positive cells in the developing
mouse embryo by in situ hybridization was reported previ-
ously.25 Although it was inferred, no independent marker or
phenotypic characteristic confirmed the identity of c-fms–
positive cells as phagocytes. As a baseline for the examination
of other putative macrophage markers, we performed a more
extensive analysis of the appearance of this marker. Cells
expressing c-fms mRNA were detected first in the yolk sac at 9.5
dpc as isolated individual cells rather than clusters associated
with blood islands, which develop in the yolk sac at 8.0 to 8.5
dpc. Among numerous embryos examined, we have never
observed any in which the first appearance of c-fms–positive
cells in the head of the embryo is clearly delayed relative to the
yolk sac. Assuming the cells are first formed in the yolk sac, the
infiltration into the embryo must occur almost immediately.
Figure 1A shows an embryo at 10 dpc, in which positive cells
are evident in the head. In some embryos at this time,
c-fms–positive cells are particularly concentrated in a band
overlying the developing heart (not shown; but see a similar
pattern with the MITF gene in Fig 4F). By 10.5 dpc, c-fms–
positive cells were first detected in the liver (Fig 1B), consistent
with the appearance of macrophage-like cells defined by other
criteria.13 Macrophages have been shown previously to be
actively involved in removing apoptotic cells to form a foot
with separate digits.16,20 To assess whether c-fms mRNA was
associated with fetal phagocytes, we concentrated particularly
on the distribution in this site. The infiltration of the limb buds
by c-fms–positive cells was actually evident well before the
onset of cell death between the digits, at 10.5 dpc, when they
accumulate in the apical ectodermal ridge (AER). At 12.5 dpc,
c-fms–positive cells still delineated the AER and they also
accumulated in the anterior ‘‘necrotic’’ zone (Fig 1C). When the
cell death commences between the digits, c-fms provides a clear
marker for phagocytic cells that infiltrate the interdigital region
from the marginal sinus (Fig 1D). At higher magnification,
many c-fms–positive cells in this site contain inclusions of
ingested pyknotic nuclei (not shown).
By 11.5 to 12.5 dpc, the degree of penetration of the probe in
whole mount in situ hybridization starts to become limiting. To
improve the penetration, some embryos were cut midsagitally
before hybridization. This approach allowed the visualization of
c-fms–positive cells lining all of the ventricular surfaces in the
brain (Fig 1E). Sectioning of the uncut whole mounts showed
the association of c-fms–positive cells with developing neuronal
cells throughout the body, including developing ganglia along
the body wall (Fig 1F), the developing eye, and along the dorsal
midline in close apposition with the neural tube (not shown).
The pattern of expression of c-fms in the vicinity of the dorsal
midline is reminiscent of migrating neural crest cells identified
with markers such as c-kit and trp-2,48 raising the possibility
that at least some of the c-fms–positive cells could be melano-
cytes. However, the distribution of these cells was not affected
by the dominant mi/mi mutation in the microphthalmic mouse,
which prevents migration of c-kit and trp-2–positive melano-
cytes (K.M. and D.A.H., unpublished results).
To confirm further the likely identity of c-fms–positive cells
and phagocytes, we analyzed serial sections of the whole
mounts. As in the footpad, throughout the body c-fms–labeled
cells were stellate in appearance and either within vessels or
very closely associated with them, indicating their likely origin
in the vasculature (Fig 1D and F). In most sections examined,
many labeled cells were clearly involved in active phagocytosis
and contained ingested pyknotic nuclei that stained intensely
with neutral red (Fig 1G). In the liver, macrophages are known
to be associated with hematopoietic islands.13 Consistent with
restriction of c-fms to the macrophage lineage, most stellate
c-fms–positive cells in this organ were associated with clusters
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of hematopoietic cells that are clearly distinct from parenchy-
mal cells (Fig 1H).
The c-fms–positive cells that were detected in this study were
more numerous and widespread than the cells that were
previously reported to express F4/80 antigen.13 Previous immu-
nocytochemical localization of F4/8011,13 (D.A.H., unpublished
results) detected small numbers of positive cells in the yolk sac
around 9.5 dpc and the first positive cells in the liver associated
with the onset of erythropoiesis in that site at 10.5 dpc. We were
first able to detect F4/80 mRNA in the liver at 11.5 dpc, but the
level of expression remained low and did not contrast well with
background staining due to the long exposure times required to
detect the signal (not shown). On this basis, the expression of
detectable F4/80 mRNA appears to be a relatively late marker
for monocytopoiesis associated with the onset of hematopoiesis
in the liver. An internal positive control confirming the rela-
tively low expression of F4/80 mRNA was the detection of
significant numbers of strongly positive maternal macrophage
in the placenta (not shown).
c-FMS Protein Is Coexpressed on Isolated Embryonic Cells
With Other Myeloid Markers, Mac-1 (CR3) and F4/80
Whole-mount in situ hybridization is difficult to adapt to
simultaneous localization of more than one marker on a
dispersed population of cells. As an independent way to confirm
that the protein product of c-fms mRNA is expressed and that it
is coexpressed with other myeloid markers, we digested em-
bryos with collagenase and dispase and examined the expres-
sion of surface markers by flow cytometry. Cells were isolated
from the embryonic liver and the remainder of the embryo at
10.5 dpc and analyzed by double-labeling with an anti–c-fms
monoclonal antibody in combination with either anti-F4/80 or
anti-Mac-1 (which recognizes the type III complement receptor,
CR3). At 10.5 dpc, in the liver (Fig 2), just over 50% of the
c-fms–positive cells also expressed detectable F4/80, and more
than 60% coexpressed Mac-1. In nonhepatic tissues, the propor-
tion of c-fms–labeled cells (1.5% to 2.0% of the total) was
greater than in the liver as expected from the mRNA localiza-
tion. Consistent with the localization of the F4/80 mRNA, less
than 20% coexpressed detectable F4/80 antigen, and even in
these, the level of expression was very low. By contrast, more
than 70% coexpressed high levels of Mac-1. Compared with the
remainder of the embryo, the liver was enriched for a popula-
tion of cells that expressed Mac-1, but not c-fms, which
probably reflects early stages of granulocyte differentiation. In
cells isolated from both the liver and embryo, the percentage of
cells coexpressing c-fms with F4/80 or Mac-1 was increased by
overnight culture in CSF-1 containing medium (data not
shown). This observation could be due to cell growth and/or
reversal of the partial loss of these surface markers during
enzymatic digestion and isolation. For this reason, the analysis
cannot be viewed as quantitative and serves primarily to prove
that the majority of c-fms–positive cells also express other
myeloid cell markers.
Mannose Receptor mRNA Colocalizes With c-fms, Whereas
the Scavenger Receptor mRNA Is Restricted to a Subset
of Phagocytes
The coexpression of Mac-1 antigen (CR3) with c-FMS
antigen shows that at least some of the embryonic phagocytes
have endocytic receptors in common with adult macrophages.
To extend knowledge of the endocytic capacity of embryonic
phagocytes, we localized the macrophage mannose receptor
(MMR)49 and macrophage scavenger receptor (MSR)50 in
embryos from 9.5 to 13.5 dpc. At all stages examined,
MMR-positive cells were as abundant in the yolk sac and
embryo as c-fms–positive cells and the perivascular locations
and cellular morphologies of labeled cells were indistinguish-
able either at the gross level (Fig 3A and B) or on examination
of sections (not shown). By contrast, MSR mRNA expression
was much more restricted. Positive cells were detected in the
heart, liver (Fig 3C), limb buds, and all over the body, but the
numbers were clearly less than observed using c-fms or MMR
probes and the expression appeared restricted to larger cells,
more closely resembling the abundance of F4/80. Examination
of sections of these embryos confirmed a distribution and
morphology of MSR-positive cells consistent with restriction to
larger c-fms–positive cells that are actively involved in phagocy-
tosis of pyknotic cells (Fig 3D; compare with Fig 1G and H).
Fig 2. FACS profiles of embryonic cells. The cells were isolated
from the liver of 10.5 dpc embryo or from the rest of the body and
stained by immunofluorescence for each of the antibody markers
shown as described in Materials and Methods. Three antibodies are
the same rat IgG2b isotype. No staining above the autofluorescence
background was observed with an irrelevant antibody of the same
isotype. The unstained cells in the upper two panels were stained
with second antibody alone. Numbers on each panel represent the
percentage of the total cell population falling within the quadrant
indicated. A total of 104 cells was counted in each experiment. The
overall pattern is representative of two independent cell isolations
from a litter of pooled embryos at 10.5 dpc.
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PU.1 mRNA Is Not Expressed at Detectable Levels
in All Embryonic Phagocytes
As noted earlier in this report, the Ets family of transcription
factors is implicated in myeloid differentiation. Clearly, if PU.1
controls the differentiation of fetal phagocytes, it should be ex-
pressed before c-fms and other myeloid markers. Whole-mount in
situ hybridization failed to detect any PU.1-positive cells at 9.5
dpc in the yolk sac or embryo (not shown) where c-fms is
readily detected (Fig 1A). In fact, cells expressing PU.1 mRNA
were not detectable until the onset of liver hematopoiesis (Fig
4A and B). It must be emphasized that the absence of detectable
PU.1 mRNA in the earlier embryo does not indicate total absence
and is clearly constrained by the sensitivity of the method. In all
experiments, embryos are incubated in the staining reagents until
any signal detected becomes maximal, or the background ‘‘nonspe-
cific’’ staining becomes evident. A number of cells detected in the
liver at this time were clearly phagocytic, suggesting that the
populations of PU.1 and c-fms–positive cells do overlap, but
c-fms is more widespread (Fig 4C). Apart from the absence of
detectable PU.1 in the yolk sac, PU.1 mRNA was detectable in
considerably fewer cells in the brain than c-fms, although the
signal intensity was comparable where it was expressed (not
shown). Another site in which it was clear that PU.1 was not
detectable in all c-fms–expressing cells was the limb. The first
detectable PU.1-positive cells in the distal part of the limbs
appeared at 12.5 dpc (c-fms cells were detectable there from
10.5 dpc) and remained at the margins (Fig 4D) at the time when
c-fms–positive phagocytes had already invaded the interdigital
spaces (see Fig 1C). This pattern of PU.1 expression in the limb
buds was very similar to that of MSR, which also accumulates
at the limb bud margins comparatively late at 12.5 dpc. In
summary, PU.1 mRNA is not expressed at detectable levels in all
c-fms–positive cells, and the pattern of expression is consistent with
restriction to a subset of cells arising later in development.
MITF Is an Early Phagocyte Marker
Of the markers examined thus far, only c-fms, MMR, and CR3
appear to be expressed on early phagocytes. Presumably, the
expression of these genes is controlled by transcription factors
expressed specifically in these cells. Other than PU.1, there are few
transcription factors known to be restricted to the macrophage
lineage. Other studies in our laboratory have implicated factors in the
basic helix-loop-helix-ZIP family in transcriptional regulation of
macrophage-specific genes, including c-fms. Among this family,
mutations in the MITF have been shown to cause osteopetrosis, a
phenotype also associated with deficiency in CSF-1. Like the PU.1
transcription factor, MITF has been shown to be expressed in adult
macrophages and osteoclasts.51 We, therefore, investigated whether
MITF mRNA is also expressed in the embryo. Figure 4E and F
shows that MITF mRNA, like c-fms mRNA, was detectable on
numerous cells in yolk sac and at the same time in the head and
in the characteristic band of cells above the early developing
heart. The location, morphology, and apparent phagocytic activity of
the labeled cells was consistent with identity or substantial overlap
of the MITF and c-fms–expressing populations.
Identification of Additional Markers Associated With
the Onset of Hematopoiesis in the Embryonic Liver
The secretory product, lysozyme, is widely expressed in
macrophages in adult mice. In the embryo, lysozyme mRNA
was not detectable in the yolk sac or embryo until 10.5 dpc,
when its expression was restricted to sparse large cells in the
liver (Fig 5A). From 11.5 dpc, lysozyme-positive cells were
present outside the liver, but were not as abundant as even
MSR-positive cells. Sections of the stained embryos indicated
heterogeneous levels of expression of the gene, with strongly
and weakly positive cells. The former were generally larger
cells, examples were observed in greatest concentration in the
pericardial wall, the peritoneal cavity, and also in the sinusoids
of the liver, and many were clearly actively involved in
phagocytosis of dying cells (Fig 5B).
Two members of the S-100 gene family, S100A8 and
S100A9, have been identified as markers of an early stage of
differentiation in bone marrow macrophage differentiation in
vitro. The initial report of cloning of these genes in mice (then
referred to as MRP8 and MRP14) reported the expression of
both mRNAs in fetal liver by RT-PCR52 so we considered them
also as possible markers for later stages of myeloid develop-
ment. As with lysozyme, neither of these S-100 genes was
detectable anywhere in the embryo or yolk sac until 11.5 dpc
(Fig 6) when the first positive cells appeared; at 11.5 dpc, the
level of expression in individual cells in the liver was so high
that the staining was evident to the naked eye. Sections of the
11.5-dpc liver showed that the dense foci of stain observed in
the whole mounts with S100A8 reflected aggregates of small
intensely staining cells (Fig 6C). Conversely, staining for
S100A9 mRNA, which was clearly less intense in whole
Fig 1. (see page 132) Localization of cells expressing c-fms mRNA
in the embryo. In all panels, c-fms mRNA was localized by whole
mount in situ hybridization as described in Materials and Methods.
The blue-purple reaction product indicates sites of expression of the
c-fms mRNA. In panels F, G, and H, the stained embryos were
embedded, sectioned, and counterstained with neutral red. Bar in
panels A through C and E represents 250 mm; in panels D, F through H,
20 mm; heart (*), forelimb (fl), hindlimb (hl), neural tube (nt). (A)
Embryo 10.5 dpc. Localization of c-fms mRNA shows a very extensive
speckled pattern throughout the embryo. Each spot is a single-
labeled cell. Labeled cells are particularly concentrated in the head,
around the branchial arches, and along the dorsal midline, although
this is not evident in a single focal plane. (B) Embryo 11 dpc. The head
of the embryo was removed before staining. At a slightly more
advanced stage than (A), the rapid appearance of c-fms–labeled cells
is evident in the liver (l). The fine speckled pattern of labeled cells is
more prominent throughout the embryo than in (A), but is less readily
demonstrated in a single focal plane. (C) Hindlimb of 12.5 dpc embryo
showing accumulation of c-fms–positive cells at the apical ectoder-
mal ridge (aer) (arrowheads) and infiltration between the digits
(arrows). (D) A section through the limb bud of 12.5 dpc embryo
showing the positive cells leaving the marginal sinus (ms) and
infiltrating the mesenchyme. (E) Whole mount of the head of a
hemisected 12.5-dpc embryo. Numerous c-fms–positive cells are
lining the ventricular surfaces of the brain, including telencephalon
(tel), diencephalon (dic), midbrain (mb), and hindbrain (hb). (F)
Section through the body wall of an 11.5-dpc embryo. Numerous
c-fms–positive cells accumulate particularly along the dorsal midline
(d). In this field, they can be seen to be closely associated with the
vascular spaces adjacent to the neural tube, but are also infiltrated
within the premuscle mass (pmm) and the epidermis (e). (G) High
power view of c-fms–positive cells from a section of brain at 11.5 dpc
shows clear evidence that many labeled cells have engulfed dying
cells and contain pyknotic nuclei stained intensely with neutral red.
(H) High-power view of c-fms–positive cell present in the liver shows
stellate morphology and intimate association with smaller hematopoi-
etic cells (double arrows).
=
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Fig 1.
Fig 3. Localization of cells expressing mRNAs encoding endocytic
receptors in the embryo. (A) Localization of MMR mRNA at 9.5 dpc.
Individual labeled cells appear in a diffuse speckled pattern (arrows)
throughout the yolk sac. (B) Localization of MMR mRNA in 11.5 dpc
embryo. MMR-positive cells are distributed very similarly to c-fms–
positive cells (Fig 1A) at the same time point as diffuse speckled
pattern throughout the embryo. In this focal plane, the particular concen-
tration of MMR-positive cells along the dorsal midline flanking the neural
tube is evident. The darkened appearance of the liver, immediately below
the forelimb bud (fl) is due to numerous MMR-positive cells, which are out
of focus in this plane (hl, hindlimb bud). (C) Localization of the MSR mRNA
at 10.5 dpc. The first labeled cells can be detected in the liver (l) at this
time, immediately below the heart (*). At this time point, few MSR-
positive cells could be detected elsewhere in the embryo. (D) The section
through the liver of an 11.5-dpc embryo stained for MSR mRNA. Some
positive cells are associated with aggregates of hematopoietic cells (to
the left of field), but many are clearly filled with engulfed cells (arrow).
Most MSR-positive cells elsewhere in this embryo are large and contain
neutral red-positive inclusions (not shown). Bar in panels A through C
represents 250 mm and in panel D, 20 mm.
;
Fig 4. Localization of cells expressing MITF and PU.1 mRNAs in
the embryo. (A) Localization of cells expressing PU.1 mRNA in the
11.5-dpc embryo. PU.1-positive cells are particularly concentrated in
the liver (l). They can be detected as a fine speckled pattern through-
out the embryo, especially flanking the neural tube at the bottom of
the field. (B) Localization of PU.1-positive cells in a sagittal section of
12.5 dpc embryo confirming that each focus of stain represents a
single labeled cell, in this case located at intervals along the dorsal
midline in mesenchyme surrounding the spinal cord. (C) A section
through the same embryo as in (B) at higher magnification. Each of
the cells expressing PU.1 mRNA in this region contains multiple foci
of neutral red staining indicating phagocytosis of pyknotic cells. (D)
Localization of cells expressing PU.1 mRNA in an embryo at 12.5 dpc
showing accumulation of the positive cells at the limb margins. Note
the distinction from the pattern obtained with c-fms in Fig 1D. (E)
Localization of MITF mRNA in the embryo. This panel shows an
embryo still surrounded by the yolk sac at 9.5 dpc. The yolk sac
contains numerous scattered positive cells. The band of positive
staining flanking the yolk sac represents expression of MITF in
trophoblasts. At higher magnification, the pattern is indistinguish-
able from MMR (3A) or c-fms.25 (F) At 10 dpc, mi-positive cells spread
from the brain throughout the body. Bar in panels A, D, and F
represents 250 mm, and in panels B and C, 20 mm.
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Fig 5. Localization of cells expressing lysozyme mRNA in the
embryo. (A) Panel shows a 10.5-dpc embryo in which lysozyme
mRNA has been detected by whole mount in situ hybridization. The
majority of labeled cells at this stage of development can be seen in
the liver (l); the band observed in the heart is due to nonspecific
trapping. A small number of cells can be seen in this focal plane in the
forelimb bud, but few cells are detected elsewhere in the embryo in
any focal plane. (B) A section through the liver of one of the embryos
stained in (A) demonstrates that the majority of labeled cells have
inclusions that stain with neutral red (arrow) and are evidently
involved in phagocytosis of dying cells. Bar in (A) represents 250 mm
and in (B), 20 mm.
Fig 6. Expression of S-100 proteins in the embryo. (A and B)
Localization of mRNA encoding the S100 proteins MRP8 (A) and
MRP14 (B) showing that both are expressed only in the liver of 11.5
dpc embryo. (C and D) Sections through the liver of embryos probed
for MRP8 (C) and MRP14 (D) expression. Panel (C) is counterstained
with hematoxylin. Note the difference between the two markers. In
(C), MRP8-positive cells are small and clustered, whereas in (D), cells
expressing MRP14 mRNA appear fewer in number, larger, and often
contain inclusions suggesting active involvement in phagocytosis.
Bar in (A) and (B) represents 250 mm and in (C) and (D), 20 mm; yolk
sac (ys), abdominal wall (abw), and peritoneum (pe).
Fig 7. Localization of c-fms mRNA in PU.1 knockout animals. (A
and B) Comparison of c-fms mRNA localization in wild-type (A) or
PU.1(2/2) (B) 11.5 dpc littermates. Note the speckled pattern through-
out the embryo representing individual c-fms–positive cells, particu-
larly concentrated in the liver (l). The apparent difference in intensity
of staining of individual cells is not significant and is due to the focal
plane and lighting. (C and D) Saggital sections through a PU.1(2/2)
embryo stained as in (B), showing that cells expressing c-fms in the
liver and limb buds have similar morphology and location to those in
wild-type mice (see Fig 1). Bar in (A) and (B) represents 250 mm and in
(C) and (D), 20 mm.
Fig 8. Differentiation of PU.1(2/2) ES cells. ES cells were culti-
vated under conditions optimized for production of macrophages as
described in Materials and Methods. (A) Comparison of the develop-
ment of embryoid bodies at day 8 of differentiation. Note that the two
PU.1(2/2) ES cells have generated smaller embryoid bodies than
either the (1/1) or (1/2) lines at this stage of differentiation. (B) After
31 days of differentiation, each of the lines of ES cells produced
adherent cells with morphology resembling macrophages. The yield
of macrophage-like cells was considerably lower at this time point in
the (2/2) cells. The cells were harvested, replated, and incubated
with latex beads as described in Materials and Methods. Panel shows
adherent cells from each culture as indicated; black staining repre-
sents the uptake of latex beads. (C) An independent experiment to
(B). In this case, adherent cells generated from differentiated ES cells
were incubated first with latex beads, then fixed, and stained using
an indirect immunoperoxidase method for expression of F4/80 anti-
gen. In the (1/1) and (1/2) cultures, the brown reaction product
demonstrating positive staining for F4/80 antigen is clearly evident
on all phagocytic cells. In the two (2/2) lines, staining can be seen
particularly in larger cells (eg, in the panel showing D3.15 cells), but
was generally not sufficiently strong to permit photographic reproduc-
tion. Original magnification for (A) was 43 and for (B) and (C), 203.
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mounts, appeared in sections to be restricted to phagocytic cells
resembling those expressing lysozyme or MSR mRNA. With-
out double-labeling, it is not possible to make a definitive
conclusion, but it would appear that the expression of the two
genes is not coincident. The lack of S100A8 or S100A9-
positive cells outside the liver, at all embryonic stages analyzed,
suggests that monocytopoiesis in the liver resembles that in
bone marrow.53,54 These two S-100 markers therefore provide
the clearest distinction between monocytopoiesis in the liver
and production of phagocytes from the yolk sac.
The Presence of Phagocytes in PU.1(2/2) Embryos
The expression of c-fms mRNA has been detected previously
in PU.1(2/2)39,41 mice despite the observation that fetal liver
cells from these animals are severely compromised in their
ability to form colonies in CSF-1 and lack expression of more
mature macrophage markers such as F4/80.55 We analyzed the
knockout embryos by whole mount in situ hybridization using
c-fms as a probe at 10.5 dpc. In keeping with the absence of
apparent overlap between PU.1 and c-fms expression at this
time (see above), there was no effect of the null mutation on the
number or location of c-fms–positive cells anywhere in the
embryo at this time (Fig 7A and B). The c-fms–positive cells
were present in the same areas as in the wild-type mice: liver,
heart, along the dorsal midline, limbs, brain, branchial arches,
and under the skin. In sections of the embryos, the morphology
and location of the labeled cells was also unaltered by the null
mutation (Fig 7C and D).
Differentiation of PU.1(2/2) ES Cells
Totipotent embryonic stem cells can form cystic embryoid
bodies and partly recapitulate normal fetal hematopoiesis in
appropriate culture conditions. Previous studies demonstrated
that production of macrophages from PU.1 null ES cells in the
presence of pokeweed mitogen spleen-conditioned medium (a
source of multiple different colony-stimulating factors) was
grossly deficient compared with heterozygous or wild-type
parent ES cells.42 We described an optimized method for
differentiating wild-type ES cells into macrophages in liquid
culture using recombinant CSF-1 and IL-3.43 We therefore
examined whether this approach would permit PU.1(2/2) ES
cells to give rise to macrophage-like cells. The analysis was
performed on two independent clones: D3.9 and D3.15.42
Differentiation of the two clones was performed for 31 days and
the adherent cells deposited by embryoid bodies were assayed
by immunohistochemistry with F4/80 antibody and phagocyto-
sis of latex beads. In both knockout clones, the production of
cystic embryoid bodies was delayed by up to a week relative to
the parent ES cells (Fig 8A), but the numbers of clones
examined is clearly not sufficient to allow determination of
whether this was due to the cloning/transfections of the ES lines
or is a consequence of the null mutation. In both of the ES cell
lines, the embryoid bodies eventually produced significant
numbers of cells that adhered to the bacteriological plastic dish
and spread with a polar morphology that was indistinguishable
from the cells produced in much larger numbers by the
heterozygous or wild-type cell (not shown). The cells produced
from PU.1 null clones resembled macrophages morphologically
and were able to ingest latex particles (Fig 8B). Immunoperoxi-
dase staining detected F4/80 antigen on the adherent cells from
null ES cells (Fig 8C), but the expression was much weaker than
in wild-type or heterozygous cells, and only some cells expressed
the marker.
DISCUSSION
The Expression of c-fms Is a Marker for Early Fetal
Phagocytes
The first part of this study extends an earlier examination of
the distribution of the mature macrophage marker, c-fms, in
mouse development. We have presented evidence that c-fms–
positive cells probably coexpress other myeloid markers, the
MMR, and the MITF transcription factor. Each of the mRNAs
was detected in cells that are concentrated in the same areas of
the embryo both at a gross anatomical level and in sections,
resemble each other morphologically, and are clearly involved
in the phagocytosis of dying cells. The FACS analysis of cells
isolated from 10.5-dpc embryos (Fig 2) showed that the
majority of c-fms–positive cells also expressed Mac-1 antigen
(CD11b/CR3), further indicating their likely identity and sug-
gesting that the type III complement receptor is another early
marker expressed by the majority of these cells. Recent
immunocytochemical study on Mac-1 expression in the embryo
confirms the presence of Mac-1–positive cells in the yolk sac
and liver from as early as 9.5 dpc.26 Similarly, MMR-positive
cells have also been identified in 9.0 dpc yolk sacs.56 Some of
the MMR expression we have observed could be attributed to
selected endothelial cells,56 but we have seen no evidence of
expression by these cells in sections. The classical endothelial
cell marker, flk-1, gives the clear reticular pattern of expression
expected from its association with a capillary network. The
pattern is quite distinct from the ‘‘speckled’’ pattern of MMR
mRNA localization in whole mount in situ hybridization of
embryos at the same age and in sections the capillary endothe-
lial cells labeled with flk-1 are morphologically distinct and
located differently from the perivascular phagocytes labeled
with MMR or c-fms (P. Koopman, personal communication,
November 1998). Hence, we feel that few, if any, of the cells
expressing detectable MMR mRNA at 9.5 to 11.5 dpc are
endothelial cells. This conclusion does not exclude the possibil-
ity of expression of MMR by vascular cells at later stages of
development.
Figure 1E and F, combined with the immunofluorescence
data on isolated cells, indicates the very large numbers of these
phagocytes in the embryo. The proportion of cells expressing
c-FMS–antigen in disaggregated 10.5 dpc embryos, approxi-
mately 2% on FACS analysis (Fig 2), is certainly an underesti-
mate, and the numbers increase substantially in the ensuing 2
days. Based on counting cells in sections, we estimate that 5%
to 10% of total cells in the embryo at 11.5 to 12.5 dpc are
c-fms–expressing phagocytes; the proportion is likely to be
higher in some areas such as the brain (Fig 1E). The PU.1-
independent early mouse phagocytes are so numerous that it is
difficult to believe that their function in development is
redundant or dispensible.
The Onset of Myelopoiesis in Liver Correlates With Altered
Expression of Macrophage-Specific Genes
In contrast to c-fms, MMR, MITF, and CR3, several markers
characteristic of adult macrophages, were only detected once
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hematopoiesis was established in the liver. The mRNA encod-
ing the S-100 proteins, S100A8 and S100A9, was shown to be
transiently expressed in presumptive myeloid progenitor cells
only in the liver, providing a striking marker of this transition.
F4/80 antigen was apparently another late marker. Previous
descriptions of embryonic mononuclear phagocytes used F4/80
antibody.13 The gene was cloned only recently and encodes an
integral membrane protein of unknown function.24 Both FACS
analysis (Fig 2) and whole mount in situ hybridization indicated
that c-fms, MMR, and Mac-1 expression precedes the appear-
ance of F4/80, and that the F4/80 antigen is probably absent, or
at very low levels, on yolk sac–derived phagocytes. The
patterns of expression of two other late markers, the secretory
product lysozyme and MSR (Figs 3 and 5) were broadly similar
to that of F4/80, although both mRNAs appeared particularly
evident on large cells involved in active phagocytosis. The
function of MSR in embryonic phagocytosis appears to be
conserved during evolution, as the phagocytes in Drosophila
also express a form of scavenger receptor.18,19 This function is
not indispensable because scavenger receptor null mice do not
have developmental abnormalities.57,58 Association of lysozyme
expression with phagocytosis is compatible with its apparent
function in adult mice59 and the low expression of lysozyme in
the fetal macrophages has also been reported by others.60
PU.1 Transcription Factor Is a Late Marker and Is Not
Required for Embryonic Phagocyte Production
The PU.1 null mutation in mice had no discernible effect on
the number or distribution of c-fms–positive phagocytes at 11.5
dpc (Fig 7). Olson et al41 used semiquantitative RT-PCR to
examine gene expression in an independent line of PU.1 null
animals and found not only c-fms, but also CD11b and CD18
(which make up Mac-1 antigen, shown to be coexpressed with
c-fms in our study) and GM-CSF receptor were unaltered at this
early stage of development. Hence, although there are some
differences in the hematopoietic phenotypes and viability of the
two published lines of PU.1(2/2) mice,39-41 both probably
retain the phagocytes we have defined. We have not performed
marker studies later in development, but the morphogenic
processes that appear to involve fetal phagocytes occur nor-
mally in the PU.1(2/2) null embryos. For example, the digits
are formed normally, and in histological sections at 12.5 to 13.0
dpc, phagocytes can be seen between the digits internalizing
pyknotic nuclei (not shown). The lack of effect of the PU.1 null
mutation on early embryonic phagocyte production is consistent
with the distribution of PU.1 mRNA, which was not detected
until the onset of liver hematopoiesis and even thereafter, in
locations such as the footpad, was detected in only a subset of
cells expressing c-fms and other early markers. Our conclusion
that PU.1 is not required for embryonic phagocyte production is
not incompatible with published evidence that it is absolutely
required for ‘‘definitive’’ myelopoiesis. In fact, there is general
agreement that the ability of the fetal liver to produce monocyte-
macrophage progenitor cells and to respond to hematopoietic
growth factors such as G-CSF, GM-CSF, and CSF-1 is almost
completely compromised by the PU.1 null mutation.61-64 These
studies involve in vitro colony assays, and the analysis of
embryos later in development (.14.5 dpc) when PU.1 is
normally expressed at readily detectable levels in the liver.
Consistent with the view that embryonic phagocytes can
develop without PU.1, we produced adherent phagocytic cells
from PU.1(2/2) ES cells. Olson et al41 also produced some
adherent cells in cultures containing a mix of colony-
stimulating factors, but dismissed their identity as macrophages.
Our system for differentiation of ES cells, using recombinant
IL-3 and CSF-1 rather than a mixed conditioned medium, is
biased towards macrophage differentiation, but there was still a
clear reduction in the number of adherent cells produced in null
cells compared with heterozygous or wild-type cells. It is
important to recognize that the ES cell differentiation system
proceeds via the formation of IL3/CSF-1–responsive colony-
forming units (CFU).39,41 The two independent PU.1 null
mutations in mice have been shown to disrupt the appearance of
such (CFU) from the yolk sac and liver,39,41,60-64 so the reduced
yield of cells seen when PU.1 null ES cells are differentiated in
vitro probably reflects a defect in production of the committed
macrophage progenitors. The in situ hybridization studies,
particularly of S100A8 and S100A9, imply that early phago-
cytes differentiate via a separate pathway (see above), and our
ES cell differentiation system has not been developed specifi-
cally for their production. If the conditions could be optimized
for embryonic as opposed to ‘‘definitive’’ phagocyte produc-
tion, we would predict that production of phagocytes would be
unaffected by the PU.1 null mutation.
Transcription of Macrophage-Specific Genes Is Not Absolutely
PU.1-Dependent
The presence of c-fms–expressing phagocytes in the PU.1
(2/2) mice indicates that PU.1 cannot be absolutely required
for transcription of the c-fms gene itself. By contrast, deKoter et
al64 reported that c-fms expression was greatly reduced in
myeloid progenitor cells isolated from 14.5 dpc PU.1(2/2)
fetal livers, and that retroviral transduction of c-fms partly
rescued the ability of the cells to proliferate, but not to
differentiate, in response to CSF-1. The apparent reduction in
c-fms expression in these studies was measured by PCR in
purified lin2 progenitor cells. It remains possible that the
investigators could have detected normal expression of c-fms in
the lin1 population of fetal liver cells from PU.1(2/2) animals,
as demonstrated from our observations. Furthermore, the possi-
bility that the PU.1 null mutation alters the distribution of c-fms
expressing cells between lin1 and lin2 populations was not
excluded. The low c-fms expression and CSF-1 unresponsive-
ness of the lin2 cells in these studies might be an indirect
consequence of lack of expression of the GM-CSFR. We and
others have shown that optimal proliferation of murine macro-
phage progenitors requires cooperation between GM-CSF and
CSF-1.65 Hence, the published data do not demonstrate unequivo-
cally that PU.1 directly controls c-fms transcription even in
adult hematopoiesis. Both the mouse and human c-fms promot-
ers have multiple functional binding sites for this factor in the
proximal promoter,28,30,31,66 but neither promoter is absolutely
PU.1-dependent, and both can be activated by other members of
the Ets transcription factor family such as Ets-2.31 Additionally,
both human67 and mouse (J. Pollard, personal communication,
July 1997) c-fms genes are expressed in trophoblasts from
separate promoters that might also be used by fetal phagocytes.
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MITF emerges from the current study as an alternative
transcription factor that could contribute to regulation of the
c-fms promoter. Our demonstration that MITF is coexpressed
with c-fms is consistent with reports of others. We find (Rehli
M., D.A.H., unpublished results) that mouse macrophages, like
those of the rat,51 use upstream promoter(s) of the MITF gene to
produce a longer form of the protein than is expressed in
melanocytes, and we have obtained evidence that an MITF
expression plasmid can transactivate the murine and human
c-fms promoters. One argument against a function for MITF in
macrophages is that the microphthalmia mutation (mi/mi) has
no effect on c-fms expression68 or on its distribution in the
embryo (not shown), but clearly does effect melanocytes (the
animals are albino). The difference may lie in the fact that
macrophages also express all three of the other members of the
MITF family, TFE3, TFEC, and TFEB; in fact, TFEC is
macrophage-restricted in its expression and shares many proxi-
mal promoter elements with c-fms.69 Additionally, there are still
other candidate regulators. For example, the murine (manu-
script submitted) and human70 c-fms promoters contain essential
conserved motifs that bind members of the C/EBP transcription
factor family, which might also contribute to expression of
c-fms before induction of PU.1.
What Happens to PU.1-Independent Phagocytes?
Both lines of PU.1(2/2) mice lack mature macrophages as
evidenced by localization of mature macrophage markers such
as F4/80,39-41,61-64 but embryonic development and organogen-
esis occurs relatively normally. Based on the data presented
here, we hypothesize that PU.1-independent phagocytes are
retained throughout development and carry out their function
normally in the null mice. If that view is correct, PU.1-
independent macrophages could be retained in the adult. In fact,
there is no published evidence that PU.1 is expressed in all adult
tissue macrophages. The PU.1-independent macrophages could
be the same as the so-called CSF-1–independent macrophages
that develop in the op/op mouse.71 If they retain their ability to
proliferate locally within tissues,72-75 they could represent a pool
of precursors of resident tissue macrophages in the adult and
therefore be quite distinct from the inflammatory macrophages
derived from circulating blood monocytes in the normal steady
state. Recent data using marrow transplanted from mice with an
integrated lacZ reporter gene supports the view that some
macrophage pools are very slowly infiltrated by cells derived
from the blood.76 Such a proposal clearly undermines the basic
concept of the mononuclear phagocyte system, namely that
tissue macrophages derive from blood monocytes, which in turn
come from marrow progenitors,1 but it might provide some
additional insight into the origins of macrophage heterogeneity.
REFERENCES
1. van Furth R, Cohn Z, Hirsh J, Humphrey J, Spector W, Lan-
gevoort H: The mononuclear phagocyte system: A new classification of
macrophages, monocytes and their precursors. Bull World Health Organ
46:845, 1972
2. Hume D, Pavli P, Donahue R, Fidler I: The effect of human
recombinant macrophage colony-stimulating factor (CSF-1) on the
murine mononuclear phagocyte system in vivo. J Immunol 141:3405,
1988
3. Sherr C, Rettenmier C, Sacca R, Rousell M, Look A, Stanley E:
The c-fms proto-oncogene product is related to the receptor for the
mononuclear phagocyte growth factor, CSF-1. Cell 41:665, 1985
4. Roth P, Stanley E: The biology of CSF-1 and its receptor. Curr Top
Microbiol Immunol 181:141, 1992
5. Lee F: The role of interleukin-6 in development. Dev Biol
151:331, 1992
6. Metcalf D: The molecular control of cell division, differentiation,
commitment and maturation in hematopoietic cells. Nature 339:27, 1989
7. Medvinsky A, Samoylina N, Muller A, Dzierzak E: An early
pre-liver intra-embryonic source of CFU-S in the developing mouse.
Nature 364:64, 1993
8. Sanchez M-J, Holmes A, Miles C, Dzierzak E: Characterisation of
the first definitive hematopoietic stem cells in the AGM and liver of the
mouse embryo. Immunity 5:513, 1996
9. Cuadros M, Coltey P, Carmen-Nieto M, Martin C: Demonstration
of a phagocytic cell system belonging to the hemopoietic lineage and
originating from the yolk sac in the early avian embryo. Development
115:157, 1992
10. Cossmann P, Eggli P, Christ B, Kurz H: Mesoderm-derived cells
proliferate in the embryonic central nervous system: Confocal micros-
copy and three dimensional visualisation. Histochem Cell Biol 107:205,
1997
11. Morioka, Y, Naito, M, Sato, T, Takahashi, K: Immunophenotypic
and ultrastructural heterogeneity of macrophage differentiation in bone
marrow and fetal hematopoiesis in mouse in vitro and in vivo. J Leukoc
Biol 55:642, 1994
12. Hume D, Perry V, Gordon S: Immunohistochemical localization
of a macrophage-specific antigen in developing mouse retina: Phagocy-
tosis of dying neurons and differentiation of microglial cells to form a
regular array in the plexiform layers. J Cell Biol 97:253, 1983
13. Morris L, Graham C, Gordon S: Macrophages in hematopoietic
and other tissues of the developing mouse detected by the monoclonal
antibody F4/80. Development 112:517, 1991
14. Abood E, Jones M: Macrophages in developing mammalian
skeletal muscle: Evidence for muscle fibre death as a normal develop-
mental event. Acta Anat (Basel) 140:201, 1991
15. De Felici M, Heasman J, Wylie C, McLaren A: Macrophages in
the urogenital ridge of the mid-gestation mouse fetus. Cell Differ
18:119, 1986
16. Hopkinson-Woolley J, Hughes D, Gordon S, Martin P: Macro-
phage recruitment during limb development and wound healing in the
embryonic and fetal mouse. J Cell Sci 107:1159, 1994
17. Franc N, Dimarq J, Lagueux M, Hoffmann J, Ezekowitz R:
Croquemort, a novel Drosophila hemocyte/macrophage receptor that
recognises apoptotic cells. Immunity 4:431, 1996
18. Pearson A, Lux A, Krieger M: Expression cloning of dSR-CI, a
class C macrophage-specific scavenger receptor from Drosophila
melanogaster. Proc Natl Acad Sci USA 92:4056, 1995
19. Abrams M, Lux A, Steller H, Krieger M: Macrophages in
Drosophila embryos and L2 cells exhibit scavenger receptor-mediated
endocytosis. Proc Natl Acad Sci USA 89:10375, 1992
20. Luciani M-F, Chimini G: The ATP binding cassette transporter
ABC1, is required for the engulfment of corpses generated by apoptotic
cell death. EMBO J 15:226, 1996
21. Sonnenfeld M, Jacobs J: Macrophages and glia participate in the
removal of apoptotic neurons from the Drosophila embryonic nervous
system. J Comp Neurol 359:644, 1995
22. Zhou L, Hashimi H, Schwartz L, Nambu J: Programmed cell
death in the Drosophila central nervous system midline. Curr Biol
5:784, 1995
23. Martin-Partido G, Cuadros M, Martin C, Coltey P, Navascues J:
Macrophage-like cells invading the suboptic necrotic centres of the
avian embryo diencephalon originate from hematopoietic precursors. J
Neurocytol 20:962, 1991
136 LICHANSKA ET AL
 For personal use only. by guest on January 23, 2014. bloodjournal.hematologylibrary.orgFrom 
24. McKnight A, Macfarlane A, Dri P, Turley L, Willis A, Gordon S:
Molecular cloning of F4/80, a murine macrophage-restricted cell
surface glycoprotein with homology to the G-protein-linked transmem-
brane 7 hormone receptor family. J Biol Chem 271:486, 1996
25. Hume D, Monkley S, Wainwright B: Detection of c-fms protoon-
cogene in early mouse embryos by whole mount in situ hybridisation
indicates roles for macrophages in tissue remodelling. Br J Haematol
90:939, 1995
26. Hughes D, Gordon S: Expression and function of the type 3
complement receptor in tissues of the developing mouse. J Immunol
160:4543, 1998
27. Zhang D, Hetherington C, Gonzalez D, Chen H, Tenen D:
Regulation of CD14 expression during monocytic differentiation in-
duced with 1 alpha, 25-dihydroxyvitamin D. J Immunol 153:3276, 1994
28. Ross I, Dunn T, Yue X, Roy S, Barnett C, Hume D: Comparison
of the expression and function of the transcription factor PU.1 (Spi-1
protooncogene) between murine macrophages and B lymphocytes.
Oncogene 9:121, 1994
29. Klemsz S, McKercher S, Celada A, van Beveren C, Maki R: The
macrophage and B-cell specific transcription factor PU.1 is related to
the ets oncogene. Cell 61:113, 1990
30. Yue X, Favot P, Dunn T, Cassady A, Hume D: Expression of
mRNA encoding the macrophage colony-stimulating factor receptor
(c-fms) is controlled by a constitutive promoter and tissue-specific
transcription elongation. Mol Cell Biol 13:3191, 1993
31. Ross I, Yue X, Ostrowski M, Hume D: Interaction between PU.1
and other ets family transcription factor promotes macrophage-specific
basal transcription initiation. J Biol Chem 273:6662, 1998
32. Buras J, Reenstra W, Fenton M: NF´A, a factor required for
maximal interleukin-1´ gene expression is identical to the ets family
member PU.1: Evidence for structural alteration following LPS activa-
tion. Mol Immunol 32:541, 1995
33. Drexler H, Gignac S: Characterization and expression of tartrate-
resistant acid phosphatase (TRAP) in hematopoietic cells. Leukemia
8:359, 1994
34. Eichbaum Q, Heney D, Raveh D, Chung M, Davidson M,
Epstein J, Ezekowitz R: Murine macrophage mannose receptor pro-
moter is regulated by the transcription factors PU.1 and Sp1. Blood
90:4135, 1997
35. Horvai A, Palinski W, Wu H, Moulton K, Kalla K, Glass C:
Scavenger receptor A gene regulatory elements target gene expression
to macrophages and to foam cells of atherosclerotic lesions. Proc Natl
Acad Sci USA 92:5391, 1995
36. Moulton K, Semple K, Wu H, Glass C: Cell-specific expression
of the macrophage scavenger receptor gene is dependent on PU.1 and a
composite AP-1/ets motif. Mol Cell Biol 14:4408, 1994
37. Pahl H, Scheibe H, Zang D, Chen H, Galson D, Maki R, Tenen
D: The proto-oncogene PU.1 regulates expression of the myeloid-
specific CD11b promoter. J Biol Chem 7:5014, 1993
38. Villiers de W, Fraser I, Hughes D, AG D, Gordon S: Macrophage-
colony-stimulating factor selectively enhances macrophage scavenger
receptor expression and function. J Exp Med 180:705, 1994
39. McKercher S, Torbett B, Anderson K, Henkel G, Vestal D,
Baribault H, Klemsz M, Feeney A, Wu G, Paige C, Maki R: Targeted
disruption of the PU.1 gene results in multiple hematopoietic abnormali-
ties. EMBO J 15:5647, 1996
40. Scott E, Simon M, Anastasi J, Singh H: Requirement of
transcription factor PU.1 in the development of multiple hematopoietic
lineages. Science 265:1573, 1994
41. Olson M, Scott E, Hack A, Su G, Tenen D, Singh H, Simon M:
PU.1 is not essential for early myeloid gene expression but is required
for terminal myeloid differentiation. Immunity 3:703, 1995
42. Henkel G, McKercher S, Yamamoto H, Anderson K, Oshima R,
Maki R: PU.1 but not ets-2 is essential for macrophage development
from embryonic stem cells. Blood 88:2917, 1996
43. Hume D, Stacey K, Cassady A, Browne C, Sweet M, Bertoncello
I: Growth and differentiation of murine macrophages, in Blackwell C,
Herzenberg L (eds): The Handbook of Experimental Immunology, vol 4
(ed 5). Boston, MA, Blackwell, 1997, p 160.1
44. Yoder M, Hiatt K, Mukherjee P: In vivo repopulating hematopoi-
etic stem cells are present in the murine yolk sac at day 9.0 postcoitus.
Proc Natl Acad Sci USA 94:6776, 1997
45. Stacey K, Fowles L, Colman M, Ostrowski M, Hume D:
Regulation of urokinase-type plasminogen activator gene transcription
by macrophage colony-stimulating factor. Mol Cell Biol 15:3430, 1995
46. Stewart C, Stewart S: Cell preparation for the identification of
leukocytes. Methods Cell Biol 41:39, 1994
47. Sudo T, Nishikawa S, Ogawa M, Kataoka H, Ohno N, Izawa A,
Hyashi S, Nishikawa S: Functional hierarchy of c-kit and c-fms in
intramarrow production of CFU-M. Oncogene 11:2469, 1995
48. Wehrle-Haller B, Weston J: Soluble and cell bound forms of steel
factor activity play distinct roles in melanocyte precursor dispersal and
survival on the lateral neural crest migration pathway. Development
121:731, 1995
49. Harris N, Super M, Rits M, Chang G, Ezekowitz R: Characteriza-
tion of the murine macrophage mannose receptor: Demonstration that
the downregulation of receptor expression mediated by interferon-
gamma occurs at the level of transcription. Blood 80:2363, 1992
50. Ashkenas J, Penman M, Vasile E, Acton S, Freeman M, Krieger
M: Structures and high and low affinity ligand binding properties of
murine type I and type II macrophage scavenger receptors. J Lipid Res
34:983, 1993
51. Weilbaecher K, Hershey C, Takemoto C, Horstmann M, Heme-
sath T, Tashjian A, Fisher D: Age-resolving osteopetrosis: A rat model
implicating microphthalmia and the related transcription factor TFE3. J
Exp Med 187:775, 1998
52. Lagasse E, Weissman I: Mouse MRP8 and MRP14, two intracel-
lular calcium-binding proteins associated with the development of the
myeloid lineage. Blood 79:1907, 1992
53. Goebeler M, Roth J, Henseleit U, Sunderkotter C, Sorg C:
Expression and complex assembly of calcium-binding proteins MRP8
and MRP14 during differentiation of murine myelomonocytic cells. J
Leukoc Biol 53:11, 1993
54. Lagasse E, Clerc R: Cloning and expression of two human genes
encoding calcium-binding proteins that are regulated during myeloid
differentiation. Mol Cell Biol 8:2402, 1988
55. Anderson K, Smith K, Conners K, McKercher S, Maki R,
Torbett B: Myeloid development is selectively disrupted in PU.1 null
mice. Blood 91:3702, 1998
56. Takahashi K, Donovan M, Rogers R, Ezekowitz R: Distribution
of murine mannose receptor expression from early embryogenesis
through to adulthood. Cell Tissue Res 292:311, 1998
57. Kodama T, Doi T, Suzuki H, Takahashi K, Wada Y, Gordon S:
Collagenous macrophage scavenger receptors. Curr Opin Lipidol 7:287,
1996
58. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M,
Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y,
Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi
T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y,
Kodama T, Horiuchi S, Takahashi K, Karkruijt J, van Berkel TJC,
Steinbrecher UP, Ishibashi S, Maeda N, Gordon S, Kodama T: A role for
macrophage scavenger receptors in atherosclerosis and susceptibility to
infection. Nature 386:292, 1997
59. Venezie R, Toews A, Morell P: Macrophage recruitment in
different models of nerve injury: Lysozyme as marker for active
phagocytosis. J Neurosci Res 40:99, 1995
60. Faust N, Huber M, Sippel A, Bonifer C: Different macrophage
populations develop from embryonic/fetal and adult hematopoietic
tissues. Exp Hematol 25:432, 1997
MONOCYTOPOIESIS IN MOUSE EMBRYO 137
 For personal use only. by guest on January 23, 2014. bloodjournal.hematologylibrary.orgFrom 
61. Anderson KL, Smith KA, Conners K, McKercher SR, Maki RA,
Torbett BE: Myeloid development is selectively disrupted in PU.1 null
mice. Blood 91:3702, 1998
62. Fisher RC, Olson MC, Pongubala JMR, Perkel JM, Atchison
ML, Scott EW, Simon MC: Normal myeloid development requires both
the glutamine-rich transactivation domain and the PEST region of
transcription factor PU.1 but not the potent acid activation domain. Mol
Cell Biol 18:4347, 1998
63. Iwama A, Zhang P, Darlington GJ, McKercher SR, Maki R,
Tenen DG: Use of RDA analysis of knockout mice to identify myeloid
genes regulated in vivo by PU.1 and C/EBPalpha. Nucleic Acids Res
26:3034, 1998
64. deKoter RP, Walsh JC, Singh H: PU.1 regulates both cytokine-
dependent proliferation and differentiation of granulocyte/macrophage
progenitors. EMBO J 17:4456, 1998
65. Breen FN, Hume DA, Weidemann MJ: Interactions between
granulocyte-macrophage colony-stimulating factor, macrophage colony-
stimulating factor and gamma interferon lead to enhanced proliferation
of murine macrophage progenitor cells. J Immunol 147:1542, 1991
66. Reddy M, Yang B, Yue X, Barnett C, Ross I, Sweet M, Hume D,
Ostrowski M: Opposing actions of c-ets, PU.1 and c-myb proto-
oncogene products in regulating the macrophage-specific promoters of
the human and mouse colony-stimulating factor-1 receptor (c-fms)
genes. J Exp Med 180:2309, 1994
67. Visvader J, Verma I: Differential transcription of exon 1 of the
human c-fms gene in placental trophoblasts and monocytes. Mol Cell
Biol 9:1336, 1989
68. Yokoi H, Nakayama H, Horie K, Fukumoto M, Fujita K, Kaneko
Y, Iwai M, Natsuyama S, Kanzaki H, Mori K: High incidence of uterine
inversion in mast cell-deficient osteopetrotic mutant mice of mi/mi
genotype. Biol Reprod 50:1034, 1994
69. Rehli M, Lichanska A, den Elzen N, Ostrowski MC, Hume DA:
TFEC is a macrophage-restricted member of the MiT-subfamily of
bHLH-ZIP transcription factors. J Immunol 162:1559, 1999
70. Yue X, Ross I, Browne C, Lichanska A, Favot P, Ostrowski M,
Hume D: Transcriptional control of the expression of the c-fms gene
encoding the receptor for macrophage colony-stimulating factor (CSF-
1). Immunobiology 195:461, 1996
71. Cecchini M, Dominguez M, Mocci S, Wetterwald A, Felix R,
Fleisch H, Chisolm O, Hofstetter W, Pollard J, Stanley E: Role of
colony stimulating factor-1 in the establishment and regulation of tissue
macrophages during postnatal development of the mouse. Development
120:1357, 1994
72. Bouwens L, Baekeland M, Wisse E: Importance of local
proliferation in the expanding Kupffer cell population of rat liver after
zymosan stimulation and partial hepatectomy. Hepatology 4:213, 1984
73. Metcalf D, Elliott M, Nicola N: The excess numbers of
peritoneal macrophages in granulocyte-macrophage colony-stimulating
factor transgenic mice are generated by local proliferation. J Exp Med
175:877, 1992
74. Sawyer R: The significance of local resident pulmonary alveolar
macrophage proliferation to population renewal. J Leukoc Biol 39:77,
1986
75. Wijffels J, Rover de Z, Beelen R, Kraal G, Rooijen van N:
Macrophage subpopulations in the mouse spleen renewed by local
proliferation. Immunobiology 191:52, 1994
76. Kennedy D, Abkowitz J: Kinetics of central nervous system
microglial and macrophage engraftment: Analysis using a transgenic
bone marrow transplantation model. Blood 90:986, 1997
138 LICHANSKA ET AL
 For personal use only. by guest on January 23, 2014. bloodjournal.hematologylibrary.orgFrom 
